Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Nifty Faces Strong Resistance At 24,500, Sensex May Climb Towards 79,000 If Bullish Momentum Continues - IBTimes India
Nifty Faces Strong Resistance At 24,500, Sensex May Climb Towards 79,000 If Bullish Momentum ContinuesIBTimes India
Stocks to Watch for June 29: HDFC Bank, Kotak Mahindra Bank, Dr Reddy’s and more
After an extended weekend, Dalal Street returns to a packed corporate news flow. From IRFC's successful OFS and Power Grid's fundraising plans to fresh developments at HDFC Bank, KEC International, Aurobindo Pharma and Bajaj Healthcare, here are the stocks likely to remain in focus on Monday.
Deutsche Bank Names Top Healthcare Stocks Led by DexCom and Insulet - Investing.com India
Deutsche Bank Names Top Healthcare Stocks Led by DexCom and InsuletInvesting.com India
Passive investing explosion: DSP’s Anil Ghelani predicts ETFs, index funds will command 30% of mutual fund industry
Passive investing is gaining rapid traction in India, with DSP’s Anil Ghelani projecting ETFs and index funds to grow from 17% to 30% of mutual fund assets within five years. The shift reflects changing investor behaviour, with passive strategies forming core portfolios and active funds playing a selective, high-alpha role.
Depth over breadth: Piramal Consumer Healthcare takes a leaf out of the modern FMCG playbook
The company is cutting new product launches by half and doubling down on quick commerce to chase a $200 million revenue target by 2030, CEO Sai Ramana Ponugoti told Mint.
Dalal Street Week Ahead: Nifty to test crucial 24,500 level; breakout may define next trend
Indian markets navigated a subdued week, ending with modest gains as Nifty hovered near a crucial resistance zone between 24,160 and 24,500. Technical indicators suggest caution, with a decisive move above this hurdle needed to fuel further upside. Investors are advised to maintain a selective approach, focusing on stock-specific opportunities while managing risk diligently. Pharma and Media sectors show relative strength, while Energy and IT lag.
Healthcare demand is outstripping supply in Noida, says MOFSL; prefers Medanta, Max Healthcare
Noida-Greater Noida is rapidly becoming a prime healthcare hub in North India, fueled by population growth and corporate expansion. Despite increasing capacity, the region faces a significant shortage of super-specialty beds. Strong demand for various medical services is evident, with hospitals experiencing rising occupancy and robust revenue. Infrastructure development further bolsters the market's long-term potential, though doctor availability remains a challenge.
Bajaj Healthcare secures SEC recommendation for Cenobamate tablets
Bajaj Healthcare announced that Subject Expert Committee (SEC) of Central Drugs Standard Control Organisation (CDSCO) has recommended for grant of approval for manufacturing and marketing of Cenobamate Tablets.
Why Equirus is avoiding loss-making startups in its ₹1,500 crore fund
Equirus new fund launch comes as India’s startup funding market becomes more selective, even though early-stage capital has held up better than late-stage funding.
BMO Market+ International Equity Fund Series Share Price | NLB:ZMPI ETF - Investing.com India
BMO Market+ International Equity Fund Series Share Price | NLB:ZMPI ETFInvesting.com India
Bajaj Healthcare becomes first in India to get SEC recommendation for Cenobamate tablets
On Thursday (June 25), shares of Bajaj Healthcare Ltd ended at ₹302.40, down by ₹9.05, or 2.91%, on the BSE.
Zydus Lifesciences enters into JV with Sunshine Healthcare
To establish pharma manufacturing facility in Sri Lanka